Patient was given 1uPRBC, vitamin K 10 mg IV.
GI was consulted, and recommended transfusing to keep Hct > 25-28%, and to consider colonoscopy and possible EGD later in the week.
Past Medical History: - Type 2 Diabetes Mellitus - Atrial Fibrillation on Coumadin - Hypertension - Hyperlipidemia - Pulmonary arterial hypertension - Chronic kidney disease - Anemia - Hyperparathyroidism s/p parathyroidectomy [**6-21**] - Pelvic fracture lateral compression type I and a left proximal  humerus fracture [**10-21**] - s/p Hysterectomy   Social History: Denies tobacco or illicit drug use.
Pertinent Results: [**2139-7-8**]: WBC 6.6, HCT 13, PLT 324, MCV 101 Na 138, K 4.8, Cl 104, Bicarb 21, BUN 116, Cr 5.1, Gluc 107 Ca [**39**].3, Mg 2.2, P 4.6 PT 19.5, PTT 29.1, INR 1.8  [**2139-7-14**] WBC-7.2 Hct-32.3* MCV-91 Plt Ct-143*  [**2139-7-15**] Hct-32.6* Glu-85 UreaN-38* Cr-2.5* Na-137 K-4.2 Cl-104 HCO3-21*  EKG: Afib @ 95 bpm, normal axis, normal interval, TWI II, III, AVF, new ST depressions V4-V6  CXR [**2139-7-8**]: No acute cardiopulmonary abnormality.
HCT remained stable for 24 hours after the procedure and the patient was discharged home with services.
Given her prior colonoscopy reports, she has known polyps and diverticuli.
She required a total of 7unts of PRBC over 48 hours given tachycardia and continued maroon stools.
[**Name10 (NameIs) **] that the patient stay off of anticoagulation for at least several weeks to allow areas of bleed to heal.
ATRIAL FIBRILLATION ON COUMADIN/EKG CHANGES: Pt's INR  was 1.8 on admission and she received Vit K 10mg IV x 1 and 2u FFP.
Her INR was 1.3 on 2nd hospital day and coumadin was held.
Anticoagulation has been discontinued because of the recent severity of GIB.
Blood sugars were not too elevated on reduced dosing, so patient discharged on reduced dose.
Pt's creatinine was closely monitored and improved with volume resuscitation.
BP was closely monitored and improved with volume resuscitation.
Home anti-hypertensive regimen including diovan, nifedipine, furosemide and hydralazine was held in ICU.
Nifedipine and Furosemide were held during the entire hospitalization and may be restarted by PCP as indicated.
Medications on Admission: Digoxin 125 mcg PO DAILY Cholecalciferol 50,000u qweek Folic Acid 1mg  PO DAILY Furosemide 80mg PO DAILY Hydralazine 50mg PO TID Lispro Protam & Lispro (75-25) Suspension 25U qAM, 40U qPM Nifedipine 90mg PO DAILY Pantoprazole 40mg PO BID Warfarin 2.5mg PO DAILY Diovan 320mg PO DAILY Simvastatin 40mg PO qHS Propanolol 80mg PO DAILY Calcium Carbonate 600 PO BID  Discharge Medications: 1.
Digoxin 125 mcg Tablet Sig: One (1) Tablet PO DAILY (Daily).
Folic Acid 1 mg Tablet Sig: One (1) Tablet PO once a day.
Hydralazine 50 mg Tablet Sig: One (1) Tablet PO TID (3 times a day).
Pantoprazole 40 mg Tablet, Delayed Release (E.C.)
Simvastatin 40 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).
Propranolol 80 mg Capsule, Sust.
Release 24 hr PO once a day.
Calcium Carbonate 600 mg (1,500 mg) Tablet Sig: One (1) Tablet PO twice a day.
Valsartan 160 mg Tablet Sig: One (1) Tablet PO DAILY (Daily): Previous dose was 320mg daily.
You received a total transfusion with 7 units of packed red blood cells.
Active bleeding was seen in the colon from what is called an AVM (arteriovenous malformation) and were stopped.
MEDICATION CHANGES (Do not restart STOPPED medications until discussing them with your primary care physician): 1.
REDUCED DOSE: Insulin 75/25: take 10 units in the morning and 15 units in the evening (previously 25 units in the morning and 40 units in the evening) 2.
STOPPED: Nifedipine 90mg daily 5.
STOPPED: Warfarin (Coumadin) 2.5mg daily  Followup Instructions: APPOINTMENT #1: Department: [**Hospital3 249**] When: TUESDAY [**2139-7-21**] at 1:10 PM With: [**Company 191**] POST [**Hospital 894**] CLINIC with Dr [**First Name4 (NamePattern1) 1060**] [**Last Name (NamePattern1) 1520**] Phone: [**Telephone/Fax (1) 250**] Building: SC [**Hospital Ward Name 23**] Clinical Ctr [**Location (un) 895**] Campus: EAST     Best Parking: [**Hospital Ward Name 23**] Garage This appointment is with a hospital-based doctor as part of your transition from the hospital back to your primary care provider.
